4.5 Article

Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states

期刊

MOLECULAR AND CELLULAR ENDOCRINOLOGY
卷 327, 期 1-2, 页码 1-12

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2010.06.013

关键词

Steroidogenic cells; Cancer; Hormones; Environmental factors; Peripheral benzodiazepine receptor; Gene expression

资金

  1. National Institutes of Health [R01 ES07747]
  2. Canada Research Chair in Biochemical Pharmacology

向作者/读者索取更多资源

Translocator protein (TSPO) is an 18 kDa high affinity cholesterol- and drug-binding protein found primarily in the outer mitochondrial membrane Although TSPO is found in many tissue types, it is expressed at the highest levels under normal conditions in tissues that synthesize steroids TSPO has been associated with cholesterol import into mitochondria, a key function in steroidogenesis, and directly or indirectly with multiple other cellular functions including apoptosis, cell proliferation, differentiation, anion transport, porphyrin transport. heme synthesis, and regulation of mitochondrial function. Aberrant expression of TSPO has been linked to multiple diseases, including cancer, brain injury, neurodegeneration, and ischemia-reperfusion injury. There has been an effort during the last decade to understand the mechanisms regulating tissue- and disease-specific TSPO expression and to identify pharmacological means to control its expression This review focuses on the current knowledge regarding the chemicals, hormones, and molecular mechanisms regulating Tspo gene expression under physiological conditions in a tissue- and disease-specific manner. The results described here provide evidence that the PKC epsilon-ERK1/2-AP-1/STAT3 signal transduction pathway is the primary regulator of Tspo gene expression in normal and pathological tissues expressing high levels of TSPO (C) 2010 Elsevier Ireland Ltd All rights reserved

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据